226 related articles for article (PubMed ID: 26984757)
1. An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells.
Peitzsch C; Cojoc M; Hein L; Kurth I; Mäbert K; Trautmann F; Klink B; Schröck E; Wirth MP; Krause M; Stakhovsky EA; Telegeev GD; Novotny V; Toma M; Muders M; Baretton GB; Frame FM; Maitland NJ; Baumann M; Dubrovska A
Cancer Res; 2016 May; 76(9):2637-51. PubMed ID: 26984757
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer: Radiotherapy induces epigenetic changes.
Stone L
Nat Rev Urol; 2016 May; 13(5):241. PubMed ID: 27041209
[No Abstract] [Full Text] [Related]
3. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
[TBL] [Abstract][Full Text] [Related]
4. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.
Young A; Berry R; Holloway AF; Blackburn NB; Dickinson JL; Skala M; Phillips JL; Brettingham-Moore KH
BMC Cancer; 2014 Nov; 14():808. PubMed ID: 25369795
[TBL] [Abstract][Full Text] [Related]
5. Impact of DNA and RNA Methylation on Radiobiology and Cancer Progression.
Chi HC; Tsai CY; Tsai MM; Lin KH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439529
[TBL] [Abstract][Full Text] [Related]
6. A feedback regulation between miR-145 and DNA methyltransferase 3b in prostate cancer cell and their responses to irradiation.
Xue G; Ren Z; Chen Y; Zhu J; Du Y; Pan D; Li X; Hu B
Cancer Lett; 2015 May; 361(1):121-7. PubMed ID: 25749421
[TBL] [Abstract][Full Text] [Related]
7. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription.
Gorodetska I; Offermann A; Püschel J; Lukiyanchuk V; Gaete D; Kurzyukova A; Freytag V; Haider MT; Fjeldbo CS; Di Gaetano S; Schwarz FM; Patil S; Borkowetz A; Erb HHH; Baniahmad A; Mircetic J; Lyng H; Löck S; Linge A; Lange T; Knopf F; Wielockx B; Krause M; Perner S; Dubrovska A
Theranostics; 2024; 14(2):714-737. PubMed ID: 38169509
[No Abstract] [Full Text] [Related]
8. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells.
Cojoc M; Peitzsch C; Kurth I; Trautmann F; Kunz-Schughart LA; Telegeev GD; Stakhovsky EA; Walker JR; Simin K; Lyle S; Fuessel S; Erdmann K; Wirth MP; Krause M; Baumann M; Dubrovska A
Cancer Res; 2015 Apr; 75(7):1482-94. PubMed ID: 25670168
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced modulation of immunogenic genes in tumor cells is regulated by both histone deacetylases and DNA methyltransferases.
Cacan E; Greer SF; Garnett-Benson C
Int J Oncol; 2015 Dec; 47(6):2264-75. PubMed ID: 26458736
[TBL] [Abstract][Full Text] [Related]
11. DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study.
Lin HY; Hung SK; Lee MS; Chiou WY; Huang TT; Tseng CE; Shih LY; Lin RI; Lin JM; Lai YH; Chang CB; Hsu FC; Chen LC; Tsai SJ; Su YC; Li SC; Lai HC; Hsu WL; Liu DW; Tai CK; Wu SF; Chan MW
Oncotarget; 2015 Jan; 6(2):915-34. PubMed ID: 25460508
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation changes following DNA damage in prostate cancer cells.
Sutton LP; Jeffreys SA; Phillips JL; Taberlay PC; Holloway AF; Ambrose M; Joo JE; Young A; Berry R; Skala M; Brettingham-Moore KH
Epigenetics; 2019 Oct; 14(10):989-1002. PubMed ID: 31208284
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer.
Gong P; Zhang T; He D; Hsieh JT
Radiat Res; 2015 Dec; 184(6):630-8. PubMed ID: 26632856
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic mechanisms underlying prostate cancer radioresistance.
Macedo-Silva C; Benedetti R; Ciardiello F; Cappabianca S; Jerónimo C; Altucci L
Clin Epigenetics; 2021 Jun; 13(1):125. PubMed ID: 34103085
[TBL] [Abstract][Full Text] [Related]
15. SFRP1 repression in prostate cancer is triggered by two different epigenetic mechanisms.
García-Tobilla P; Solórzano SR; Salido-Guadarrama I; González-Covarrubias V; Morales-Montor G; Díaz-Otañez CE; Rodríguez-Dorantes M
Gene; 2016 Nov; 593(2):292-301. PubMed ID: 27570179
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of the placentally imprinted tumor suppressor gene TFPI2 in prostate carcinoma.
Ribarska T; Ingenwerth M; Goering W; Engers R; Schulz WA
Cancer Genomics Proteomics; 2010; 7(2):51-60. PubMed ID: 20335518
[TBL] [Abstract][Full Text] [Related]
18. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
Kondo Y; Shen L; Cheng AS; Ahmed S; Boumber Y; Charo C; Yamochi T; Urano T; Furukawa K; Kwabi-Addo B; Gold DL; Sekido Y; Huang TH; Issa JP
Nat Genet; 2008 Jun; 40(6):741-50. PubMed ID: 18488029
[TBL] [Abstract][Full Text] [Related]
19. Distinct promoters, subjected to epigenetic regulation, drive the expression of two clusterin mRNAs in prostate cancer cells.
Bonacini M; Coletta M; Ramazzina I; Naponelli V; Modernelli A; Davalli P; Bettuzzi S; Rizzi F
Biochim Biophys Acta; 2015 Jan; 1849(1):44-54. PubMed ID: 25464035
[TBL] [Abstract][Full Text] [Related]
20. Clusterin is epigenetically regulated in prostate cancer.
Rauhala HE; Porkka KP; Saramäki OR; Tammela TL; Visakorpi T
Int J Cancer; 2008 Oct; 123(7):1601-9. PubMed ID: 18649357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
